ArticleTransactions of the American Ophthalmological Society2009
The Ahmed glaucoma valve in neovascular glaucoma (An AOS Thesis).
Article in Transactions of the American Ophthalmological Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.
- The efficacy and safety of anti-vascular endothelial growth factor combined with Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma: a systematic review and meta-analysis.Frontiers in medicine · 2024Pooled it
- Surgical Outcomes of A-Stream Shunt Implantation in Neovascular Glaucoma: A Single-Center Retrospective Cohort Study.Korean journal of ophthalmology : KJO · 2026Article
- Intermediate-term outcomes of Ahmed glaucoma valve implantation in glaucoma patients.BMC ophthalmology · 2025Article
- New retinoblastoma (RB) drug delivery approaches: anti-tumor effect of atrial natriuretic peptide (ANP)-conjugated hyaluronic-acid-coated gold nanoparticles for intraocular treatment of chemoresistant RB.Molecular oncology · 2024Article
- Ahmed Glaucoma Valve Implantation in Jordan: Indications and Complications.Clinical ophthalmology (Auckland, N.Z.) · 2024Article
- Baerveldt glaucoma implant with SupramidInternational journal of ophthalmology · 2024Article
- Etiology, pathogenesis, and diagnosis of neovascular glaucoma.International journal of ophthalmology · 2022Review
- Autologous Scleral Pocket Technique for Ahmed Glaucoma Valve Implantation with Pars Plana Tube Insertion for Neovascular Glaucoma.Journal of clinical medicine · 2021Article
- Transscleral cyclophotocoagulation with MicroPulseInternational ophthalmology · 2021Observational
- Neovascular glaucoma - A review.Indian journal of ophthalmology · 2021Review
- Use of laser iridoplasty in iris incarceration of a glaucoma drainage device.American journal of ophthalmology case reports · 2020Article
- Comparison between the Express Implant and Transscleral Diode Laser in Neovascular Glaucoma.Journal of ophthalmology · 2020Article
- Comparison of Silicone- and Porous-Plate Ahmed Glaucoma Valves.Medical devices (Auckland, N.Z.) · 2020Article
- Efficacy of Ahmed Glaucoma Valve Implantation on Neovascular Glaucoma.International journal of medical sciences · 2019Article
- Baerveldt or Ahmed glaucoma valve implantation with pars plana tube insertion in Japanese eyes with neovascular glaucoma: 1-year outcomes.Clinical ophthalmology (Auckland, N.Z.) · 2018Article
- Ahmed Valves vs Trabeculectomy Combined with Pans Plana Vitrectomy for Neovascular Glaucoma with Vitreous Hemorrhage.European journal of ophthalmology · 2017Article
- Observational
- Surgical treatment of neovascular glaucoma with Ex-PRESS glaucoma shunt: Case report.Medicine · 2017Article
- Neovascular glaucoma: a retrospective review from a tertiary center in China.BMC ophthalmology · 2016Review
- Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma.BMC ophthalmology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the results of Ahmed glaucoma valve surgery in neovascular glaucoma and control patients.
methodsIn this retrospective comparative study, we reviewed 76 eyes of 76 patients, comparing the surgical outcomes in control patients (N=38) to matched neovascular glaucoma patients (N=38). Success was defined as intraocular pressure (IOP) > or =6 mm Hg and < or =21 mm Hg, without further glaucoma surgery, and without loss of light perception.
resultsAverage follow-up for control and neovascular glaucoma patients was 18.4 and 17.4 months, respectively (P = .550). At last follow-up, mean IOP was 16.2 +/- 5.2 mm Hg and 15.5 +/- 12.5 mm Hg (P = .115) in control and neovascular glaucoma patients, respectively. Life-table analysis showed a significantly lower success for neovascular glaucoma patients compared with controls (P = .0096), with success at 1 year of 89.2% and 73.1%, at 2 years of 81.8% and 61.9%, and at 5 years of 81.8% and 20.6% for control and neovascular glaucoma eyes, respectively. Cox proportional hazards regression analysis showed neovascular glaucoma as a risk factor for surgical failure (odds ratio, 5.384, 95% CI, 1.22-23.84, P = .027). Although IOP control and complications were comparable between the two groups, visual outcomes were worse in neovascular glaucoma patients, with 9 eyes (23.7%) with neovascular glaucoma compared with no controls losing light perception vision (P = .002). The majority with loss of vision (5 of 9) had successful control of IOP during the postoperative period.
conclusionNeovascular glaucoma patients have greater risk of surgical failure after Ahmed glaucoma valve surgery compared with controls. Despite improved mean IOP with drainage implants, visual outcomes may be poor, possibly due to progression of underlying disease.
Indexed as
Identifiers
20126506PMC2814575W1602322251What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.